Covington Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $49K | Hold |
618
| – | – | ﹤0.01% | 572 |
|
|
2022
Q2 | $46K | Hold |
618
| – | – | ﹤0.01% | 580 |
|
|
2022
Q1 | $56K | Hold |
618
| – | – | ﹤0.01% | 562 |
|
|
2021
Q4 | $69K | Hold |
618
| – | – | ﹤0.01% | 501 |
|
|
2021
Q3 | $78K | Hold |
618
| – | – | ﹤0.01% | 481 |
|
|
2021
Q2 | $84K | Hold |
618
| – | – | ﹤0.01% | 468 |
|
|
2021
Q1 | $84K | Hold |
618
| – | – | ﹤0.01% | 427 |
|
|
2020
Q4 | $87K | Hold |
618
| – | – | ﹤0.01% | 407 |
|
|
2020
Q3 | $69K | Hold |
618
| – | – | ﹤0.01% | 418 |
|
|
2020
Q2 | $69K | Buy |
618
+32
| +5% | +$3.57K | ﹤0.01% | 407 |
|
|
2020
Q1 | $45K | Buy |
586
+8
| +1% | +$614 | ﹤0.01% | 433 |
|
|
2019
Q4 | $55K | Hold |
578
| – | – | ﹤0.01% | 459 |
|
|
2019
Q3 | $44K | Hold |
578
| – | – | ﹤0.01% | 458 |
|
|
2019
Q2 | $51K | Hold |
578
| – | – | ﹤0.01% | 441 |
|
|
2019
Q1 | $52K | Hold |
578
| – | – | ﹤0.01% | 419 |
|
|
2018
Q4 | $41K | Buy |
+578
| New | +$41K | ﹤0.01% | 453 |
|